Overexpression of leucine-rich α2-glycoprotein-1 is a prognostic marker and enhances tumor migration in gastric cancer.

about

Overexpression of leucine-rich α2-glycoprotein-1 is a prognostic marker and enhances tumor migration in gastric cancer.

Item

http://www.wikidata.org/entity/Q42288581

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Overexpression of leucine-rich ...... r migration in gastric cancer.

@en

Overexpression of leucine-rich ...... r migration in gastric cancer.

@nl

type

Item

label

Overexpression of leucine-rich ...... r migration in gastric cancer.

@en

Overexpression of leucine-rich ...... r migration in gastric cancer.

@nl

prefLabel

Overexpression of leucine-rich ...... r migration in gastric cancer.

@en

Overexpression of leucine-rich ...... r migration in gastric cancer.

@nl

P1476

Overexpression of leucine-rich ...... or migration in gastric cancer

@en

P2093

Kiyokazu Nakajima

http://www.w3.org/2001/XMLSchema#string

Koji Tanaka

http://www.w3.org/2001/XMLSchema#string

Makoto Yamasaki

http://www.w3.org/2001/XMLSchema#string

Shuji Takiguchi

http://www.w3.org/2001/XMLSchema#string

Takahito Sugase

http://www.w3.org/2001/XMLSchema#string

Tomoki Makino

http://www.w3.org/2001/XMLSchema#string

Tsuyoshi Takahashi

http://www.w3.org/2001/XMLSchema#string

Yasuhiro Miyazaki

http://www.w3.org/2001/XMLSchema#string

Yukinori Kurokawa

http://www.w3.org/2001/XMLSchema#string

P2860

Periodicity of leucine and tandem repetition of a 24-amino acid segment in the primary structure of leucine-rich alpha 2-glycoprotein of human serum

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

Unidentified curved bacilli on gastric epithelium in active chronic gastritis

LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling.

Feasibility of neoadjuvant S-1 and oxaliplatin followed by surgery for resectable advanced gastric adenocarcinoma.

Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients.

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.

Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma.

A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures.

P304

2052-2060

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CAS.13329

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28746773

http://www.w3.org/2001/XMLSchema#string

P921

overexpression

P932

5623762

http://www.w3.org/2001/XMLSchema#string